ALLBIRDS INC-CL A (BIRD) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:BIRD • US01675A2087

3.16 USD
-0.18 (-5.39%)
Last: Feb 11, 2026, 08:08 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to BIRD. BIRD was compared to 45 industry peers in the Textiles, Apparel & Luxury Goods industry. While BIRD seems to be doing ok healthwise, there are quite some concerns on its profitability. BIRD is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • BIRD had negative earnings in the past year.
  • In the past year BIRD has reported a negative cash flow from operations.
  • In the past 5 years BIRD always reported negative net income.
  • BIRD had a negative operating cash flow in each of the past 5 years.
BIRD Yearly Net Income VS EBIT VS OCF VS FCFBIRD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M

1.2 Ratios

  • BIRD has a Return On Assets of -69.80%. This is amonst the worse of the industry: BIRD underperforms 93.33% of its industry peers.
  • BIRD has a Return On Equity of -161.17%. This is amonst the worse of the industry: BIRD underperforms 88.89% of its industry peers.
Industry RankSector Rank
ROA -69.8%
ROE -161.17%
ROIC N/A
ROA(3y)-40.03%
ROA(5y)-28%
ROE(3y)-68.68%
ROE(5y)-46.4%
ROIC(3y)N/A
ROIC(5y)N/A
BIRD Yearly ROA, ROE, ROICBIRD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 200 400 600 800

1.3 Margins

  • With a Gross Margin value of 38.77%, BIRD is not doing good in the industry: 71.11% of the companies in the same industry are doing better.
  • BIRD's Gross Margin has declined in the last couple of years.
  • BIRD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 38.77%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.86%
GM growth 5Y-3.48%
BIRD Yearly Profit, Operating, Gross MarginsBIRD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • BIRD does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for BIRD has been increased compared to 1 year ago.
  • Compared to 5 years ago, BIRD has less shares outstanding
  • BIRD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BIRD Yearly Shares OutstandingBIRD Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M
BIRD Yearly Total Debt VS Total AssetsBIRD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

  • Based on the Altman-Z score of -6.57, we must say that BIRD is in the distress zone and has some risk of bankruptcy.
  • BIRD has a worse Altman-Z score (-6.57) than 86.67% of its industry peers.
  • BIRD has a Debt/Equity ratio of 0.24. This is a healthy value indicating a solid balance between debt and equity.
  • BIRD's Debt to Equity ratio of 0.24 is fine compared to the rest of the industry. BIRD outperforms 73.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Altman-Z -6.57
ROIC/WACCN/A
WACC11.14%
BIRD Yearly LT Debt VS Equity VS FCFBIRD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

2.3 Liquidity

  • BIRD has a Current Ratio of 2.37. This indicates that BIRD is financially healthy and has no problem in meeting its short term obligations.
  • BIRD's Current ratio of 2.37 is fine compared to the rest of the industry. BIRD outperforms 68.89% of its industry peers.
  • A Quick Ratio of 1.10 indicates that BIRD should not have too much problems paying its short term obligations.
  • The Quick ratio of BIRD (1.10) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.37
Quick Ratio 1.1
BIRD Yearly Current Assets VS Current LiabilitesBIRD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 14.91% over the past year.
  • Looking at the last year, BIRD shows a very negative growth in Revenue. The Revenue has decreased by -21.98% in the last year.
  • BIRD shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.41% yearly.
EPS 1Y (TTM)14.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%10.49%
Revenue 1Y (TTM)-21.98%
Revenue growth 3Y-11.9%
Revenue growth 5Y-0.41%
Sales Q2Q%-23.28%

3.2 Future

  • The Earnings Per Share is expected to grow by 18.37% on average over the next years. This is quite good.
  • BIRD is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.18% yearly.
EPS Next Y18.3%
EPS Next 2Y15.22%
EPS Next 3Y18.37%
EPS Next 5YN/A
Revenue Next Year-14.94%
Revenue Next 2Y-6.84%
Revenue Next 3Y-0.18%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BIRD Yearly Revenue VS EstimatesBIRD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2030 100M 200M 300M 400M 500M
BIRD Yearly EPS VS EstimatesBIRD Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -5 -10 -15

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for BIRD. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BIRD. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BIRD Price Earnings VS Forward Price EarningsBIRD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BIRD Per share dataBIRD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10 15

4.3 Compensation for Growth

  • A more expensive valuation may be justified as BIRD's earnings are expected to grow with 18.37% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.22%
EPS Next 3Y18.37%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • BIRD does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALLBIRDS INC-CL A

NASDAQ:BIRD (2/11/2026, 8:08:16 PM)

3.16

-0.18 (-5.39%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)11-06
Earnings (Next)N/A
Inst Owners39.59%
Inst Owner Change-1.36%
Ins Owners3.11%
Ins Owner Change-1.01%
Market Cap25.94M
Revenue(TTM)160.64M
Net Income(TTM)-83.70M
Analysts80
Price Target14.28 (351.9%)
Short Float %16.1%
Short Ratio12.32
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.83%
Min EPS beat(2)11.58%
Max EPS beat(2)28.09%
EPS beat(4)4
Avg EPS beat(4)19.35%
Min EPS beat(4)7.68%
Max EPS beat(4)30.07%
EPS beat(8)8
Avg EPS beat(8)21.74%
EPS beat(12)12
Avg EPS beat(12)19.14%
EPS beat(16)14
Avg EPS beat(16)15.59%
Revenue beat(2)1
Avg Revenue beat(2)-2.39%
Min Revenue beat(2)-5.57%
Max Revenue beat(2)0.79%
Revenue beat(4)2
Avg Revenue beat(4)-0.46%
Min Revenue beat(4)-5.57%
Max Revenue beat(4)4.91%
Revenue beat(8)5
Avg Revenue beat(8)-0.08%
Revenue beat(12)7
Avg Revenue beat(12)-0.53%
Revenue beat(16)9
Avg Revenue beat(16)0.03%
PT rev (1m)0%
PT rev (3m)27.27%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-6.58%
EPS NY rev (1m)0%
EPS NY rev (3m)1.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.42%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.57%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.16
P/FCF N/A
P/OCF N/A
P/B 0.5
P/tB 0.5
EV/EBITDA N/A
EPS(TTM)-10.28
EYN/A
EPS(NY)-7.87
Fwd EYN/A
FCF(TTM)-8.05
FCFYN/A
OCF(TTM)-7.65
OCFYN/A
SpS19.57
BVpS6.33
TBVpS6.32
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -69.8%
ROE -161.17%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 38.77%
FCFM N/A
ROA(3y)-40.03%
ROA(5y)-28%
ROE(3y)-68.68%
ROE(5y)-46.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.86%
GM growth 5Y-3.48%
F-Score2
Asset Turnover1.34
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 42.69%
Cap/Sales 2.05%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.37
Quick Ratio 1.1
Altman-Z -6.57
F-Score2
WACC11.14%
ROIC/WACCN/A
Cap/Depr(3y)99.47%
Cap/Depr(5y)150.28%
Cap/Sales(3y)5.66%
Cap/Sales(5y)6.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%10.49%
EPS Next Y18.3%
EPS Next 2Y15.22%
EPS Next 3Y18.37%
EPS Next 5YN/A
Revenue 1Y (TTM)-21.98%
Revenue growth 3Y-11.9%
Revenue growth 5Y-0.41%
Sales Q2Q%-23.28%
Revenue Next Year-14.94%
Revenue Next 2Y-6.84%
Revenue Next 3Y-0.18%
Revenue Next 5YN/A
EBIT growth 1Y16.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year36.97%
EBIT Next 3Y22.47%
EBIT Next 5YN/A
FCF growth 1Y-32.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-85.17%
OCF growth 3YN/A
OCF growth 5YN/A

ALLBIRDS INC-CL A / BIRD FAQ

Can you provide the ChartMill fundamental rating for ALLBIRDS INC-CL A?

ChartMill assigns a fundamental rating of 2 / 10 to BIRD.


What is the valuation status for BIRD stock?

ChartMill assigns a valuation rating of 0 / 10 to ALLBIRDS INC-CL A (BIRD). This can be considered as Overvalued.


How profitable is ALLBIRDS INC-CL A (BIRD) stock?

ALLBIRDS INC-CL A (BIRD) has a profitability rating of 0 / 10.


Can you provide the financial health for BIRD stock?

The financial health rating of ALLBIRDS INC-CL A (BIRD) is 4 / 10.